Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extended Family”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Testing effectiveness (Phase 2)Looking for participantsNCT06525636
What this trial is testing

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin Co., Ltd. 39
Large-scale testing (Phase 3)Ended earlyNCT01589237
What this trial is testing

Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.

Who this might be right for
Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01576484
What this trial is testing

Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)

Who this might be right for
HypercholesterolemiaHeterozygous Familial Hypercholesterolemia
Regeneron Pharmaceuticals 58
Not applicableStudy completedNCT01910701
What this trial is testing

Extension Study of the Family Spirit Program

Who this might be right for
Parenting
Johns Hopkins Bloomberg School of Public Health 92
Not applicableLooking for participantsNCT06644144
What this trial is testing

P4O2 ILD Extension

Who this might be right for
Interstitial Lung DiseasePulmonary FibrosisInterstitial Lung Fibrosis+7 more
Amsterdam UMC, location VUmc 450
Large-scale testing (Phase 3)Study completedNCT03067441
What this trial is testing

Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Disease
Esperion Therapeutics, Inc. 1,462
Testing effectiveness (Phase 2)Study completedNCT02890992
What this trial is testing

An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Who this might be right for
Hypercholesterolaemia
Sanofi 42
Not applicableStudy completedNCT02974309
What this trial is testing

Family Routines Enhancing Adolescent Diabetes by Optimizing Management

Who this might be right for
Type 1 Diabetes
University of Arizona 115
Not applicableStudy completedNCT03255122
What this trial is testing

Technology and Early Anxiety Treatment

Who this might be right for
Anxiety Disorders
Florida International University 40
Not applicableWithdrawnNCT06671561
What this trial is testing

Product Surveillance Registry; Ear, Nose and Throat - EXTEND Cohort

Who this might be right for
Chronic Rhinosinusitis (CRS)
Medtronic
Large-scale testing (Phase 3)Looking for participantsNCT05682378
What this trial is testing

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

Who this might be right for
Heterozygous or Homozygous Familial Hypercholesterolemia
Novartis Pharmaceuticals 195
Testing effectiveness (Phase 2)Active Not RecruitingNCT03536767
What this trial is testing

Open-Label Study of AG10 in Patients with Cardiomyopathy

Who this might be right for
Amyloid Cardiomyopathy
Eidos Therapeutics, a BridgeBio company 55
Not applicableStudy completedNCT01274143
What this trial is testing

Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)

Who this might be right for
Colorectal Cancer
University of Utah 496
Large-scale testing (Phase 3)Study completedNCT03659916
What this trial is testing

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Who this might be right for
Progressive Familial Intrahepatic Cholestasis
Albireo, an Ipsen Company 116
Testing effectiveness (Phase 2)Study completedNCT03060577
What this trial is testing

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Who this might be right for
Atherosclerotic Cardiovascular DiseaseSymptomatic AtherosclerosisType2 Diabetes+1 more
Novartis Pharmaceuticals 382
Large-scale testing (Phase 3)Looking for participantsNCT07771465
What this trial is testing

The Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Who this might be right for
Symptomatic Genetic Dilated Cardiomyopathy (DCM)
Kardigan, Inc. 332
Large-scale testing (Phase 3)Active Not RecruitingNCT04988386
What this trial is testing

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

Who this might be right for
Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company 389
Large-scale testing (Phase 3)Study completedNCT00991146
What this trial is testing

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 19
Not applicableLooking for participantsNCT06195553
What this trial is testing

Application and Effectiveness of the STEPPS in Patients with BPD, Extending to Their Families with the FC Program

Who this might be right for
Borderline Personality Disorder (BPD)
Universitat Jaume I 120
Next Page